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A salivary metabolite signature 
that reflects gingival host-microbe 
interactions: instability predicts 
gingivitis susceptibility
Marcela M. fernandez-Gutierrez  1,2, Sultan imangaliyev1,3,6, Andrei prodan1,4,6, 
Bruno G. Loos1,5, Bart J. F. Keijser1,3,6 & Michiel Kleerebezem1,2*
Several proteins and peptides in saliva were shown to stimulate gingival wound repair, but the role of 
salivary metabolites in this process remains unexplored. In vitro gingival re-epithelialization kinetics 
were determined using unstimulated saliva samples from healthy individuals collected during an 
experimental gingivitis study. Elastic net regression with stability selection identified a specific 
metabolite signature in a training dataset that was associated with the observed re-epithelialization 
kinetics and enabled its prediction for all saliva samples obtained in the clinical study. This signature 
encompassed ten metabolites, including plasmalogens, diacylglycerol and amino acid derivatives, 
which reflect enhanced host-microbe interactions. This association is in agreement with the positive 
correlation of the metabolite signature with the individual’s gingival bleeding index. Remarkably, intra-
individual signature-variation over time was associated with elevated risk for gingivitis development. 
Unravelling how these metabolites stimulate wound repair could provide novel avenues towards 
therapeutic approaches in patients with impaired wound healing capacity.
Oral wounds can result from daily activities (e.g. tooth brushing, chewing and eating), but also from surgery, 
trauma or presence of inflammatory conditions such as periodontal diseases. Unlike skin injuries, wounds in the 
oral cavity are characterized by a higher repair rate and lack of scar formation1. The rapid wound repair observed 
in the oral cavity has been attributed to several factors. First, oral epithelial cells have a higher turnover rate than 
skin cells allowing a faster repair of the oral mucosa2. Second, there is a better microcirculation in the oral mucosa 
than in the skin, facilitating faster recruitment of immune cells to the site of injury that can effectively remove 
phagocytized bacteria and cell debris3. Third, the presence of saliva provides a humid environment that promotes 
re-epithelialization through a faster cell migration4. In addition, the role of individual salivary proteins or pep-
tides on maintenance of oral health has been extensively studied5. For example, epidermal growth factor (EGF)6 
and transforming growth factor alpha (TGFα)7 play an important role during oral wound repair through the 
activation of several signalling cascades that lead to migration, differentiation, and proliferation of cells. Similarly, 
vascular endothelial growth factor (VEGF) is involved in re-epithelialization, extracellular matrix regulation and 
angiogenesis, which are all critical processes that take place during wound repair8. Certain antimicrobial pep-
tides present in saliva such as β-defensins and cathelicidin have also been reported to have growth stimulating 
properties in keratinocytes and lung cells9,10. In particular, histatin (Hst) 1 and Hst 2, primarily recognized for 
their antimicrobial activity in the oral cavity, have been identified as potent stimulators of cell migration via acti-
vation of the ERK 1/2 pathway in oral cells11. At the same time, saliva is also a rich source of metabolites or small 
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molecules (<2,000 Da), which unlike the salivary proteome, have not been characterized in detail. Recently, a 
total 853 human salivary metabolites were identified and annotated using a multi-platform approach in combina-
tion with computer aided literature-mining12. This metabolite collection complemented the work of the Human 
Metabolome Database (HMDB) (http://www.hmdb.ca/) which provides the most up-to-date and comprehensive 
library of the human metabolome13.
In a previous study, we examined the changes in the salivary metabolome of 61 healthy adults at 5 timepoints 
during an experimental gingivitis challenge intervention14. The intervention required the volunteers to refrain 
from any form of oral hygiene for two weeks, resulting in plaque accumulation and induction of mild inflam-
mation (i.e. gingivitis). Using untargeted metabolomics, we measured and identified 497 metabolites in a total of 
305 unstimulated saliva samples collected during the challenge period of the study14. Here we identified a metab-
olite signature composed of ten compounds of which the relative concentrations are able to predict the effect 
of a saliva sample on gingival re-epithelialization kinetics using a recently developed in vitro model15. Several 
of the compounds of the signature are associated with increased cell damage and inflammation possible due to 
increased host-microbe interactions. This was reflected by a positive association between the predicted gingival 
re-epithelialization capacity elicited by the saliva samples and the inflammatory state of the periodontal tissues at 
the moment of saliva sampling. Finally, instability over time of the salivary metabolite signature was correlated 
with an increased response to the experimental gingivitis challenge.
Results
Stimulatory capacity of saliva on re-epithelialization is highly variable among individuals and 
potentially influenced by salivary metabolites. To investigate if changes in the salivary metabolome 
during the development of gingivitis could alter the salivary capacity to induce wound repair, we evaluated the 
effect of unstimulated saliva samples collected at the baseline, challenge intervention, and resolution phases of 
a previous study14 (also see study design in Methods section and Fig. 1a) on the re-epithelialization kinetics of 
gingival epithelial cells (i.e. Ca9–22 cell line). Confluent cell monolayers were scratched and treated with unstim-
ulated saliva samples obtained from 9 randomly selected participants at the 7 timepoints of the study (Day -14 
to Day 21; Fig. 1b). Live-imaging followed by modelling of the re-epithelialization curves were conducted to 
obtain kinetic parameters that quantitatively describe wound repair (μm and A parameters; see15,16 and Methods 
section for details). The overall impact of the treatment with specific saliva samples on wound-repair kinetics was 
assessed by the re-epithelialization performance value (μm*A) that was expressed relative to the untreated control 
within the same assay run15. Even though the effect of unstimulated saliva on oral re-epithelialization kinetics was 
highly variable among individuals (Fig. 1b), the saliva samples derived from most individuals resulted in signifi-
cantly enhanced re-epithelialization kinetics relative to the non-treated control. The stimulatory effect observed 
for saliva samples from specific individuals did not show a consistent change during the time-course of the study 
(Fig. 1b,c), indicating that the wound-repair capacity of saliva was not consistently influenced during the experi-
mental gingivitis challenge. In addition, neither daily intake of erythritol or gender had a significant influence on 
the salivary capacity to promote wound repair (Fig. S1), and no significant association was found between total 
protein content and the capacity of the saliva samples to promote gingival re-epithelialization (Fig. S2).
Metabolite signature in saliva is associated with re-epithelialization kinetics in oral cells. To 
investigate whether the chemical composition of saliva influences the differential re-epithelialization capacity 
observed between samples, we performed elastic net regressions17 with stability selection18. To increase the power 
of this analysis, the kinetic parameters determined for the saliva samples collected during the challenge interven-
tion period (Day 0 to Day 14, see Fig. 1a) was expanded with 20 randomly selected samples (Table S1; different 
individuals and different timepoints) for which metabolome data was available (i.e. excluding samples collected 
at Day -14 and 21). The filtered and scaled metabolite dataset (see Methods section for more details) together 
with each of the scaled re-epithelialization parameter values (i.e. μm, A, and μm*A) were employed in the elas-
tic net regressions. The best fit of the model (R2 = 0.54) with the lowest normalized root mean-square-error19 
(NRMSE = 16.58) when compared with the actual measurements were obtained with the performance values 
(μm*A) (Fig. 2a). Therefore, these values were used as a training dataset to perform elastic net regression analysis 
in combination with stability selection18, leading to the identification of a set of metabolites that collectively were 
associated with the observed oral re-epithelialization (Table 1). Notably, the use of the μm parameter in the elastic 
net regression also resulted in a very good fit (R2 = 0.52, NRMSE = 20.19, see Fig. S3) and the selection of a partly 
overlapping metabolite set compared to the analysis using the performance values, which included the plas-
malogen lipids and the O-sulfo-L-tyrosine (Table S2). This finding suggests that the μm parameter has a greater 
contribution to the model than the A parameter.
All the metabolites in the identified signature had a high stability (>0.6), indicating that the metabolites were 
selected in more than 60% of the subsampling iterations (n = 100) performed. In particular, O-sulfo-L-tyrosine 
had a very high stability and was selected in 91% of the iterations. Due to the high stability of O-sulfo-L-tyrosine 
in the elastic net regression, we evaluated the potential of this single metabolite as a biomarker of saliva-induced 
re-epithelialization by performing a linear regression to model the relationship between the relative concentra-
tion of O-sulfo-L-tyrosine and the re-epithelialization kinetics measured in the in vitro assay. The fit of this single 
metabolite (R2 = 0.23, p-value = 4.21 × 10−5) was much lower than the fit obtained in a multiple linear regression 
that included all the metabolites in the identified signature (R2 = 0.74, p-value = 4.80 × 10−14). Moreover, anal-
ysis of variance between the two models showed that the addition of all the metabolites in the signature signifi-
cantly contributed to the observed re-epithelialization kinetics (F = 2.01, p-value = 2 × 10−11). These observations 
strongly support the higher biomarker-value of the metabolite signature as compared to the best-performing 
single metabolite within the signature.
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Besides choline phosphate, all other selected metabolites in the elastic net regression had a positive aver-
age weight, indicating that increasing concentrations of these metabolites were associated with enhanced 
re-epithelialization kinetics. A hierarchical clustering of the relative concentrations of the metabolites in the 
identified salivary signature revealed two main clusters in the saliva sample set (Fig. 2b). In agreement with the 
elastic net regression analysis, the majority of the saliva samples in the upper cluster (I) contained relatively high 
concentrations of the signature metabolites that led to high re-epithelialization kinetics in gingival cells. Only 
for choline phosphate, the relation between its relative concentration and the re-epithelialization kinetics was 
inversed. Conversely, the lower cluster (II) grouped saliva samples with relative low concentration of most sig-
nature metabolites and induced lower re-epithelialization kinetics. This cluster differentiation is further substan-
tiated by the significant difference in re-epithelialization kinetics between the sample groups (p-value < 0.0001) 
(Fig. 2c). Notably, hierarchical clustering of randomly selected metabolites from the dataset consistently failed 
to separate the saliva samples into two distinctive clusters with distinct re-epithelialization kinetics (a total of 
70 heatmaps; see Fig. S4 for two random examples), underpinning the specificity of the metabolite signature 
identified.
Figure 1. Study design and saliva effect on re-epithelialization kinetics. (a) Design of the challenge 
intervention, randomized study, adapted from Prodan et al.14. (b) Effect of the selected unstimulated saliva on 
re-epithelialization kinetics. Volunteers 1, 3, 16, 21, 55 and 57 corresponded to the control group. Volunteers 
8, 26 and 36 corresponded to the treatment group. Dashed line represents the non-treated control. (c) Re-
epithelialization capacity of unstimulated saliva collected at different timepoints of the challenge intervention 
study. Significant differences from the non-treated control were assessed by a one-way ANOVA followed by a 
Dunnett’s test for multiple comparisons (*P < 0.05; **P < 0.001; ***P < 0.0001).
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Prediction and validation of oral re-epithelialization kinetics using the salivary metabo-
lite signature. To validate the predictive potential of the metabolite signature, we used it to predict the 
re-epithelialization capacity of the remaining 242 unstimulated saliva samples collected during the challenge 
intervention period of the study (n = 305) (Fig. 1a). Subsequently, we selected previously untested saliva samples 
that were predicted to have among the highest and lowest stimulatory capacity (n = 11 in each group) in the 
re-epithelialization assay. The re-epithelialization kinetics of gingival cells stimulated with these samples was 
determined and showed that the metabolite signature could successfully predict the relative re-epithelialization 
capacity of the saliva samples (Fig. 3). Similar to the training dataset, the metabolite signature separated the 
samples in two distinct clusters (I and II; Fig. 3a) that induced significantly higher (cluster I) and lower (cluster 
II) wound repair kinetics (p-value = 0.02) (Fig. 3b). Moreover, Spearman correlation analysis corroborated a sig-
nificant association between the observed and predicted kinetics of re-epithelialization (r = 0.44, p-value = 0.043, 
n = 22). Taken together, the combination of several metabolites in the signature presented in this study has a 
powerful predictive potential of the effect of the saliva in oral re-epithelialization.
Relevance of the metabolite signature in relation to gingival bleeding and the magnitude of 
the response to the challenge. Periodontal diseases are multifactorial inflammatory diseases that lead 
Figure 2. Salivary metabolite signature related to observed re-epithelialization kinetics. (a) Performance of 
the elastic net regression through the (μm*A) parameter values. (b) Hierarchical clustering heatmap displaying 
relative metabolite concentrations of the signature and observed re-epithelialization kinetic values (μm*A) for 
the training dataset. (c) Re-epithelialization performance induced by saliva samples of clusters I and II derived 
from the hierarchical clustering. Significant difference was assessed by a two-tailed t-test (***P < 0.0001).
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to damage of the periodontal tissues supporting the teeth20. The gingival bleeding index21 has long been used 
as a reliable clinical parameter for evaluating the inflammatory conditions of the periodontium and over time 
has been modified in several ways, for example, by scoring for the absence or presence of gingival bleeding on 
marginal probing (BOMP)22. To evaluate if there was an association between the re-epithelialization capacity 
predicted by the metabolite signature and this clinical parameter (percentage of gingival bleeding), we conducted 
Spearman correlation analysis at the baseline of the study (Day 0). This analysis revealed a significant positive 
association between these two variables with a correlation coefficient of 0.30 (p-value = 0.018) (Fig. 4). This 
suggests that volunteers whose saliva samples displayed a higher stimulatory effect on re-epithelialization had 
increased gingival inflammation in comparison to the individuals whose saliva samples elicited lower stimulatory 
capacity. Next, we evaluated the predictive capacity of the metabolite signature at baseline in relation with the 
response to the challenge which was reflected by the change in gingival bleeding between the peak and baseline 
of the challenge (Δ BOMP%). Individuals were median split into two groups: (1) those whose samples were pre-
dicted to have higher re-epithelialization capacity and (2) those with lower capacity. No significant difference was 
found between the two groups (Fig. S5), suggesting that the metabolite signature has no predictive capacity with 
respect to the magnitude of the response to the challenge.
Nevertheless, we set out to investigate if intra-individual variation of the predicted re-epithelialization capac-
ity of the saliva samples collected at different timepoints could influence the magnitude of the response to the 
challenge. For this, we calculated the coefficient of variation23, which describes the variability of the predicted 
repair values relative to the mean re-epithelialization capacity of the samples collected for each of the volun-
teers in the study (n = 61). Spearman correlation analysis revealed a significant positive association (r = 0.33, 
Metabolite name Description Stability
Average 
Weight
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4) Plasmalogen 0.69 0.14
1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1) Plasmalogen 0.67 0.09
1-oleoyl-2-linoleoyl-glycerol (18:1/18:2) Diacylglycerol 0.75 0.11
5-aminovalerate Lysine metabolism 0.67 0.07
choline phosphate Phospholipid metabolism 0.63 −0.17
imidazole lactate Histidine metabolism 0.88 0.17
Indolelactate Tryptophan metabolism 0.72 0.10
N-acetylproline Urea cycle; arginine and proline metabolism 0.79 0.14
O-sulfo-L-tyrosine Chemical 0.91 0.21
phosphoenolpyruvate (PEP) Glycolysis, gluconeogenesis and pyruvate metabolism 0.73 0.14
Table 1. Metabolite signature. Elastic net regression with stability selection was performed to select a set of 
metabolites that were associated to re-epithelialization kinetics (μm*A).
Figure 3. Predictive capacity of the salivary metabolite signature. (a) Hierarchical clustering heatmap 
displaying relative metabolite concentrations of the signature and re-epithelialization performance for the 
validation dataset. (b) Re-epithelialization performance observed in clusters I and II. Significant difference was 
assessed by a two-tailed t-test (*P < 0.05).
6Scientific RepoRtS |         (2020) 10:3008  | https://doi.org/10.1038/s41598-020-59988-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
p-value = 0.008) between the coefficient of variation of the predicted re-epithelialization capacity and the change 
in gingival bleeding during the trial (Δ BOMP%) (Fig. 5), suggesting that the individuals with higher variability 
in their metabolite signature display an increased response to the accumulation of plaque during the experimental 
gingivitis challenge and potentially have a higher risk to develop gingivitis.
Discussion
Human saliva is secreted from three pairs of major salivary glands (parotid, submandibular, and sublingual 
glands) as well as numerous minor salivary glands lying beneath the oral mucosa24. The protective role of saliva in 
the maintenance of oral health can be attributed to the presence of its inorganic and organic constituents. Among 
the organic constituents, saliva contains a myriad of proteins and peptides that have been shown to modulate dif-
ferent aspects of oral health, including enzymatic digestion, food tasting and swallowing, lubrication, protection 
against pathogenic microorganisms, remineralization, and stimulation of tissue repair3,5,24–26.
In recent years, metabolomic analysis of human saliva have revealed that this ‘biofluid’ is also a rich source of 
low molecular weight metabolites such as lipids, amino acids, vitamins, organic acids, thiols, carbohydrates, and 
their derivatives, which can be important indicators of physiological or pathological states12,27,28. Different studies 
have shown that specific changes in the metabolic profiles of saliva can be associated with the presence of perio-
dontal diseases29 and oral cancer30. Importantly, metabolites from blood can pass into the saliva through transcel-
lular, intracellular or paracellular routes involving passive diffusion or active transport within the salivary glands 
or the gingival sulcus31. As a consequence salivary metabolites have the potential to provide a window to the rest of 
the body that has been used in the early detection of bacterial infections32, breast cancer, and pancreatic cancer30.
Figure 4. Saliva re-epithelialization capacity in relation to gingival bleeding. Spearman correlation analysis 
between the predicted saliva re-epithelialization capacity and the percentage of gingival bleeding in 61 
individuals at the baseline (Day 0) of the study.
Figure 5. Effect of intra-individual variation in response to the experimental gingivitis challenge. Spearman 
correlation analysis between the coefficient of variation (%), obtained with the predicted re-epithelialization 
values calculated during the challenge period (Day 0, 2, 5, 9, and 14), and change in gingival bleeding between 
the baseline and the peak of the challenge (ΔBOMP%) in 61 individuals.
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In this study we used the metabolite profiles of 305 unstimulated saliva samples collected from 61 healthy 
volunteers at 5 timepoints during an experimental gingivitis challenge intervention14 to investigate their influ-
ence on re-epithelialization kinetics using a quantitative in vitro scratch model15. The re-epithelialization kinetics 
(in particular the overall performance value μm*A) obtained in a training set of saliva samples (n = 63) enabled 
the identification of a specific salivary metabolite signature (10 metabolites) that allowed the prediction (and 
partial verification) of the re-epithelialization stimulatory capacity of saliva samples obtained in an experimental 
gingivitis challenge model. Importantly, regression analyses revealed that the metabolite signature correlated 
much stronger with the observed re-epithelialization kinetics than single metabolites within the signature, which 
clearly illustrates the benefit of combinatorial multi-factorial biomarkers as compared to single factor biomarkers. 
Similarly, in a recent proteomics study, the authors identified a panel of clinical biomarkers in saliva that reflect 
the transition between health and periodontal disease and could serve as a better diagnostic tool as opposed to 
the classical single biomarker evaluation33.
The metabolite signature (Table 1) contained several metabolites that are associated with host-microbe inter-
actions, cellular degradation, and in some cases inflammation. The 1-(1-enyl-palmitoyl)-2-arachidonyl-GPE 
and 1-(1-enyl-palmitoyl)-2-oleoyl-GPC are plasmalogens, a type of membrane phospholipids that contain a 
vinyl-ether bond at the sn-1 position of the glycerophospholipid backbone34. Plasmalogens comprise ~18% of the 
phospholipid mass in humans and help maintaining the physical bilayer properties of cell membranes35, while 
the hydrogen atoms adjacent to the vinyl-ether bond are preferentially oxidized when exposed to free radicals 
and thereby can act as antioxidants36,37. Untargeted metabolic profiling of saliva from healthy and periodontal 
patients, revealed an association between periodontal disease and elevated levels of degradation products of sev-
eral macromolecules, including glycerolphospholipids29. Moreover, elevated concentrations of various plasmalo-
gen derivates in serum and/or synovial fluid have been correlated with the severity of inflammatory diseases 
like obesity-associated osteoarthritis (OA) and rheumatoid arthritis in both human38 and mice39. Interestingly, 
the metabolite 1-oleoyl-2-linoeoyl-glycerol (diacylglycerol; DAG) has recently been associated with cell damage 
and the formation of spatially organized lipid domains around the site of injury40, in which DAG was shown to 
be required for regulation of GTPases, Rho and Cdc42 involved in cortical cytoskeleton repair40. Choline phos-
phate (ChoP) is an intermediate in the synthesis of phosphatidylcholine, a major phospholipid of eukaryotic 
cell membranes41. ChoP has been shown to potentiate the mitogenic effect of insulin in NIH 3T3 fibroblasts42,43, 
and therefore it remains unclear why increasing concentrations of this metabolite in saliva resulted in reduced 
re-epithelialization capacity. Taken together, higher concentrations of these lipid metabolites (with the exception 
of choline phosphate) in saliva may result from increased mucosal damage and cellular decay through enhanced 
host-microbe interactions, as was already proposed by the authors of the salivary metabolome study29. Moreover, 
such elevated host-microbe interplay is in line with the higher levels of modified amino acids that (potentially) 
result from bacterial metabolism, i.e. 5-aminovalerate, imidazole lactate, indolelactate, N-acetylproline, and 
O-sulfo-L-tyrosine. In particular, elevated levels of 5-aminovalerate, a metabolite of the foul-smelling diamine 
cadaverine that is produced by microbial protein hydrolysis44, has been associated with patients with chronic 
periodontitis45. Finally, many secreted and transmembrane proteins that play a role in various biological processes 
involved in wound repair (e.g. blood coagulation, optimal rolling of leukocytes on endothelial cells upon tissue 
damage, chemokine receptor signalling, and extracellular matrix remodelling) are commonly post-translationally 
modified when they pass through the trans-golgi compartment to introduce O-sulfo-tyrosine residues46–48. Hence, 
the elevated levels of this metabolite in saliva may reflect increased bacterial hydrolysis of host-derived proteins.
Overall, the metabolite signature identified in this study encompasses metabolites that could reflect enhanced 
host-microbe interactions at the mucosal tissues in the oral cavity and may thus, reflect a chemical signature 
for mild mucosal damage. Higher concentrations of most of the metabolites in the signature (with the excep-
tion of choline phosphate) was associated with accelerated gingival wound repair in vitro, which could reflect 
the cellular response to the proposed mucosal damage, and which is in agreement with the signature’s associ-
ation with elevated gingival bleeding scores. These results seem to support earlier findings on the proteomic 
profile of the secretome of gingival epithelium in response to biofilm formation in which deregulation of host 
responses involved in cytoskeletal rearrangement, stress responses and epithelial tissue integrity, among others 
were observed49,50.
Intriguingly, we also found a significant positive association between the intra-personal variation of the 
metabolite signature and the magnitude of the response to the challenge, reflected by increased gingival bleeding 
scores during the experimental gingivitis trial. One may speculate that stability of host-microbe interactions in 
the oral cavity, and its corresponding salivary metabolite signature, could reflect a healthy state. In such context, 
individuals with unstable host-microbe interactions and higher variability of the metabolite signature may be at 
higher risk to respond more strongly under a challenge, like the gingivitis challenge model tested in this study.
The mechanism by which the combination of these metabolites is able to modulate oral re-epithelialization 
remains unclear at this stage. They may directly, or indirectly activate wound-repair responses in gingival cells, 
which is reflected by enhanced re-epithelialization in the in vitro scratch assay, and this model may serve as an attrac-
tive assay system to unravel the mechanism of action of the metabolite signature. Finally, the identified signature 
may open promising avenues for the development of novel treatment strategies in patients with mucositis, recurrent 
oral aphthous ulcers or Sjögren’s syndrome, disease states that are all characterized by impaired wound healing51,52.
Methods
Study population and design. A challenge intervention, randomized, blinded study was carried out in 
the Academic Centre for Dentistry Amsterdam (ACTA) within the framework of the Top Institute of Food and 
Nutrition (TIFN) project “An exploratory study on the dynamic (microbial, biochemical and immunological) 
interactions of the oral ecosystem during induction of mild gingival inflammation”. The study population con-
sisted of 61 systemically healthy adults (21 males, 40 females), between 18 and 55 years of age, with no apparent 
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periodontitis or dental caries. Inclusion and exclusion criteria were previously described by Prodan et al.14. The 
study consisted of three phases: baseline, challenge intervention, and resolution phase (see Fig. 1a). The baseline 
phase consisted of two weeks (Day -14 to Day 0) in which the volunteers of the treatment group (n = 20) were 
requested to start taking six doses of erythritol per day (2 g/tablet) for the entire duration of the study (5 weeks), 
while the remaining participants (n = 41) were requested to follow their normal routine. Erythritol is a non-ca-
loric polyol that is used as sugar substitute and has been shown to reduce plaque accumulation, limit growth of 
Streptococcus mutans, and lower caries rates in vivo53–55. The challenge intervention was based on the experimen-
tal gingivitis protocol developed by Löe et al.56 and encompassed a two-week period (Day 0 to Day 14) in which 
all participants (n = 61) were asked to refrain from any form of oral hygiene (i.e. tooth brushing, flossing, chewing 
gum, mouth wash), resulting in plaque accumulation and induction of mild gingival inflammation. This was 
followed by a resolution phase of one week (Day 14–Day 21) in which the volunteers reinitiated standardized oral 
hygiene practices to restore normal oral homeostasis.
Ethical considerations. The study protocol was reviewed and approved by the Medical Ethics Committee of 
the Vrije Universiteit Medical Centre (2014_505) and registered at the Central Committee on Research Involving 
Human Subjects (CCMO). The study was conducted according to the Declaration of Helsinki57 of the World 
Medical Association. All volunteers signed an informed consent form.
Unstimulated saliva collection. Unstimulated saliva samples were collected at seven timepoints across 
the study (Day -14, Day 0, Day 2, Day 5, Day 9, Day 14 and Day 21). Sample collection occurred between 9.00 and 
12.00 AM. Volunteers were instructed not to eat or drink two hours prior to the appointment. For sample collec-
tion, volunteers were told to accumulate saliva on the floor of their mouth, without facial or tongue movements, 
and spit every 30 seconds for 5 minutes into a sterile polypropylene tube, which was kept on ice. Samples were 
centrifuged (10,000 × g, 10 minutes at 4 °C) to remove epithelial cell debris, bacteria, and food residues, and then 
stored at −80 °C. Total protein content was determined as described in58 using a Pierce BCA Protein Assay Kit 
(Thermo Fisher Scientific, MA, USA).
Metabolomics analysis. Untargeted metabolite profiling of the saliva samples was outsourced to 
Metabolon® (Durham, NC, USA) and processed as described previously14. Briefly, metabolite extracts 
were divided into five aliquots: two for analysis by two separate reverse phase ultrahigh performance liquid 
chromatography-tandem mass spectroscopy (RP/UPLC-MS/MS) methods with positive ion mode electros-
pray ionization (ESI), one for analysis by RP/UPLC-MS/MS with negative ion mode ESI, one for analysis by 
hydrophilic-interaction chromatography (HILIC)/UPLC-MS/MS with negative ion mode ESI, and one sam-
ple was reserved as backup. All methods used an ACQUITY UPLC System (Waters Corporation, MA, USA) 
and a Q-Exactive™ high-resolution, accurate-mass spectrometer (Thermo Fisher Scientific) interfaced with a 
heated electrospray ionization (HESI-II) source and Orbitrap mass analyzer operated at 35,000 mass resolution. 
Extraction of raw data, quality control processing and identification of peaks were performed using Metabolon’s 
hardware and software. Identification of peaks was carried out by comparison with the Metabolon’s reference 
library, which contains the retention time/index (RI), mass to charge ratio (m/z), and chromatographic data on 
all molecules present in the library. Inter-day instrument tuning differences were corrected for each compound 
by registering the medians equal to one in every run and normalizing each data point proportionally. Normalized 
peak areas were scaled by the median value of each compound. Metabolome analyses were performed on the five 
timepoints (Day 0, Day 2, Day 5, Day 9 and Day 14) corresponding to the challenge intervention phase of the 
study (see also Fig. 1a). The complete dataset can be found in Prodan et al. (Supplementary Material 1)14.
Assessment of bleeding on marginal probing (BOMP). Assessment of bleeding on marginal prob-
ing (BOMP) was performed as previously described by Oliveira et al.22 at the baseline of the study (Day -14 
and Day 0), at the peak of the challenge intervention (Day 14), and after the resolution period (Day 21). The 
teeth with exception of third molars were clinically examined at six sites per tooth (disto-vestibular, vestibular, 
mesio-vestibular, disto-lingual, lingual and mesio-lingual) in two contralateral quadrants (i.e. one upper and one 
lower). The number of gingival units that bled upon marginal probing within 30 seconds was recorded with scores 
from 0 to 2 (0 = no bleeding, 1 = pinprick, 2 = excessive bleeding). Gingival bleeding was expressed as a percent-
age of sites that bled upon probing (Table S3). The response to the challenge was determined by the Δ BOMP%, 
which was obtained by calculating the difference between the percentage of gingival bleeding at the end (Day 14) 
and at the beginning (Day 0) of the challenge.
Cell line maintenance. The human epithelial gingival cell line, Ca9–22 (JCRB0625), was purchased from 
the National Institute of Biomedical Innovation JCRB Cell Bank (Osaka, Japan). Ca9–22 cells were routinely cul-
tured at 37 °C in a humidified atmosphere containing 5% CO2, in Dulbecco’s Modified Eagle Medium (DMEM) 
containing Glutamax (Invitrogen, Paisley, UK) and supplemented with 10% fetal calf serum (FCS), 100 U/mL 
penicillin and 100 μg/mL streptomycin. The cells were passaged every three to four days.
Scratch assay and re-epithelialization kinetics modelling. Scratch assays and modelling of 
re-epithelialization kinetics were performed as previously described15. A detailed protocol is available in 
Protocol Exchange16. Briefly, cells were seeded in 96-well plates (BD Falcon™, Corning, NY, USA) at a density 
of 3.5 × 104 cells/well and incubated overnight. Confluent cell monolayers were starved in FCS-free DMEM for 
2 hours during which the cytoplasm and nuclei were fluorescently labelled with 2 μM CellTracker™ Red CMTPX 
(Molecular Probes, OR, USA) and 2 μg/ml Hoechst 33342 (Molecular Probes), respectively. After incubation, 
the HTSScratcher (Peira, Antwerpen, BE) was used to introduce uniform longitudinal scratches in the cell mon-
olayers of the multi-well plate, and wells were washed twice with phosphate-buffered saline (PBS) to remove 
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cell debris followed by immediate addition of the treatments in FCS-free DMEM. Unstimulated saliva samples 
were tested in duplicate in a 1:4 ratio (unstimulated saliva: FCS-free DMEM) and FCS-free DMEM was used as 
non-treated control. As positive control of cell migration and proliferation, we used 4 ng/ml human transform-
ing growth factor alpha (TGFα; R&D Systems, MN, USA). A combination of p38 (SB203580; Cell Signaling 
Technology, MA, USA) and MEK1/2 (U0126, Cell Signaling Technology) inhibitors served as negative control 
at a concentration of 10 μM each. Bright-field and fluorescent images (577 nm and 350 nm) of the same frame 
of each well were acquired every 20 minutes during a period of 5 hours with the BD Pathway 855 Bioimaging 
System (BD Biosciences, CA, USA) using a 4x objective under controlled conditions (37 °C and 5% CO2). Image 
segmentation and feature extraction was performed using CellProfiler (version 2.1.1.) and FCS Express 4 Plus 
(De Novo Software, CA, USA) was used to record the number of cells infiltrating into the scratched area over 
time. The enumeration of infiltrating cells was modelled using the modified Gompertz function59 to extract three 
kinetic wound-repair parameters (μm, A, and λ). The μm parameter represents the repair rate (cells minute−1) and 
the A parameter represents the maximum number of cells inside the scratched area at the plateau phase of the 
repair curve. Previous studies have shown that the third parameter obtained by kinetic modelling (λ, representing 
the point of infliction or lag-phase) has limited biological relevance when using the Ca9–22 gingival cells as the 
migration process in this particular cell line starts almost instantly after the scratch is introduced15. Treatments of 
which the modelled wound-repair curve showed a goodness of fit (R2) lower than 0.9 were discarded from further 
analysis. Notably, a fully integrated pipeline for image segmentation, enumeration of cells inside and outside the 
scratched area, kinetic modelling and parameter extraction is available online through the Galaxy platform16,60. 
Finally, the overall wound repair-performance was assessed by the (μm*A) value15 that is expressed relative to the 
non-treated control (FCS-free DMEM).
Elastic net regression and stability selection method. Elastic net regression17 with stability selection18 
was performed to select a set of features (i.e. metabolites) that were related to re-epithelialization kinetics. The 
elastic net regression with stability selection was implemented in Python using the scikit-learn package v.0.16.161. 
The elastic net balancing parameter was set at 0.3 to 0.8 in 20 steps, whereas the alpha factor parameter ranged 
from 10−2 to 10+2 in 150 steps. A total of 63 unstimulated saliva samples collected from 19 volunteers during the 
challenge phase (Day 0 to Day 14) of an earlier experimental gingivitis study14 were tested in duplicates in the 
re-epithelialization model to obtain the kinetic parameters (μm, A, and μm* A) that were used to train the model 
(Table S1). The features were selected based on their stability after 100 runs of feature selection modelling on 
random data shuffles using the stability selection procedure. Model hyperparameters were estimated using an 
exhaustive grid search within a 5-fold cross-validation procedure on 80% of the training dataset and the mod-
el’s generalization error was assessed on the remaining 20% test dataset. The performance measure used for a 
regression task is a Normalized Root Mean Square Error (NRMSE). Missing metabolite values were assumed to 
be below the detection limits and were imputed with the minimum detected value for that metabolite across all 
samples. Metabolites with more than 25% missing measurements were removed from the dataset. The filtered 
metabolite measurements were scaled by removing the mean value of each metabolite (zero-mean) and then 
divided by the standard deviation. Re-epithelialization parameter values were zero-mean scaled. The selected 
features were used to predict the in vitro re-epithelialization kinetics (μm* A) of the remaining 242 unstimulated 
saliva samples collected during the challenge phase14 from a total of 61 individuals (Table S3).
Calculation of the coefficient of variation of the predicted re-epithelialization values. 
Intra-individual variation of the predicted re-epithelization capacity of the saliva samples collected during the 
challenge period (Day 0, 2, 5, 9, and 14) was determined by calculating their coefficient of variation (CV)23, 
defined as the ratio of the standard deviation (σ) to the mean (μ).
CV 100σ
µ
=






×
To avoid approximation of the coefficient of variation to infinity when mean values are close to zero, the pre-
dicted re-epithelialization values were unscaled by adding 1+ the absolute minimum value of the dataset to each 
predicted value (Table S3).
Other statistical analyses. Statistical significance tests and correlation analyses were performed in 
GraphPad Prism version 6.0 (GraphPad Software, CA, USA). Linear and multiple linear regressions were per-
formed in R. Heatmaps with hierarchical clustering were created in R using the heatmap.2 function of the gplots 
package version 3.0.162.
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